Biosolution Co.Ltd Cash Flow-to-Debt Ratio
Biosolution Co.Ltd cash flow-to-debt ratio. Biosolution Co.Ltd (086820) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of ₩17.41 Million could theoretically repay 0% of its total liabilities (₩36.25 Billion) in one year. Check total reinvestment intensity of Biosolution Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biosolution Co.Ltd (2015–2024)
Cash flow-to-debt ratio of Biosolution Co.Ltd from 2015 to 2024. Historical debt coverage capacity for Biosolution Co.Ltd across 10 annual periods. Check 086820 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Biosolution Co.Ltd Cash Flow-to-Debt Ratio by Year (2015–2024)
Biosolution Co.Ltd cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Biosolution Co.Ltd. For the full cash flow conversion analysis, see Biosolution Co.Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | ₩-2.29 Billion | ₩36.21 Billion | ▼ -246.8% |
| 2023 | 0.04x | ₩2.16 Billion | ₩50.22 Billion | ▲ +154.1% |
| 2022 | -0.08x | ₩-3.81 Billion | ₩47.96 Billion | ▼ -4815.9% |
| 2021 | 0.00x | ₩83.29 Million | ₩49.39 Billion | ▲ +100.3% |
| 2020 | -0.54x | ₩-1.69 Billion | ₩3.13 Billion | ▲ +23.4% |
| 2019 | -0.70x | ₩-2.61 Billion | ₩3.71 Billion | ▼ -360.2% |
| 2018 | 0.27x | ₩1.03 Billion | ₩3.80 Billion | ▲ +1117.6% |
| 2017 | -0.03x | ₩-78.53 Million | ₩2.96 Billion | ▲ +96.5% |
| 2016 | -0.77x | ₩-2.07 Billion | ₩2.70 Billion | ▲ +8.8% |
| 2015 | -0.84x | ₩-2.02 Billion | ₩2.40 Billion | — |